Wicki Andreas's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Mar 4, 2022
- Accession no.
- 0001104659-22-030268
- Filed
- Mar 4, 2022
- Trade date
- Mar 1-3, 2022
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $24.2M. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wicki AndreasCIK 0001511472 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | SSaleDisposed | −92,501 | $40.24 | −$3,722,240.24 | 4,452,742 | Indirect | |
| Mar 2, 2022 | Common Stock | SSaleDisposed | −328,927 | $40.52 | −$13,328,122.04 | 4,123,815 | Indirect | |
| Mar 3, 2022 | Common Stock | SSaleDisposed | −175,000 | $41.01 | −$7,176,750 | 3,948,815 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.